Cirius Therapeutics
Cirius Therapeutics is a company developing an insulin sensitizer for the treatment of non-alcoholic steatohepatitis.
1
Funding Rounds
$40.0m
Money raised
Overview
Cirius Therapeutics is a company developing an insulin sensitizer for the treatment of non-alcoholic steatohepatitis.
- Website:
| Name | Phone | Social networks | |
|---|---|---|---|
| De**** Fe**** | - | - | - |
| Bo* Ba***** | - | - | - |
| Da**** Es*** | - | - | - |
| Ro**** L. Ze*** | - | - | - |
| Ni**** Ku*** | - | - | - |
| Mi***** Ja******* | - | - | - |
Funding series
Funding Series Analysis
The company Cirius Therapeutics has raised a total of $40m in funding over 1 rounds.
Key Insights:
- Cirius Therapeutics Series A round, April 2017: $40m
Cirius Therapeutics Series A round, April 2017
$40m
Industries
Cirius Therapeutics is active in the following industries: